Diabetic Macular Edema (DME) Withdrawn Phase 2 Trials for Aflibercept (DB08885)

Also known as: Diabetic Macular Edema(DME) / Diabetic Macular Oedema / Macular Edema, Diabetic / Diabetic Macular Edema / Macular edema due to diabetes mellitus (disorder) / Diabetic retinal oedema / Diabetic retinal edema

IndicationStatusPhase
DBCOND0060562 (Diabetic Macular Edema (DME))Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04588948A Pharmacokinetic stuDy of intRavitreal Aflibercept Injection in Vitrectomized and Non-vitrectomized Eyes With Diabetic Macular EdemaTreatment
NCT03920878Cataract DME - Peri vs. IntraopTreatment
NCT03629210Combination OZURDEX® & EyLea® vs. OZURDEX® Monotherapy in IncompLete-Responders wIth Diabetic Macular EdemaTreatment